Clinical effects of meal intake time intervention in patients with type 2 diabetes: a prospective observational study

Clinical effects of extension of meal intake time in patients with type 2 diabetes: a prospective observational study - Meal intake time intervention study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046893

Enrollment

Registered

2022-02-13

Start date

2022-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Provide normal nutritional guidance plus instruct to double their meal intake time for dinner. Provide normal nutritional guidance.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The selection criteria for the subjects are as follow. 1. Patients who have been diagnosed as type 2 diabetes. 2. Over 20 years old.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the subjects are as follow. 1. Subjects with acute and/or chronic inflammation 2. Subjects with fresh cardiovascular and/or cerebrovascular diseases 3. Subjects with liver cirrhosis. 4. Subjects with severe respiratory disease or severe heart failure 5. Subjects with alcoholicsm or medicinal intoxication 6. Subjects with psychosis 7. Subjects who doctors judge as unfitness

Design outcomes

Primary

Measure	Time frame
Comparing the difference in HbA1c between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner.	—

Secondary

Measure	Time frame
1: Comparing the difference in body weight and/or BMI between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. 2: Comparing the difference in several factors as follow between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 3: Association the change of HbA1c and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.body weight (kg), BMI (kg/mm2) 10.detail of medication and number of take medicine 4: Association the change of body weight and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.HbA1c (%) 10.detail of medication and number of take medicine	—

Measure

Time frame

1: Comparing the difference in body weight and/or BMI between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. 2: Comparing the difference in several factors as follow between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 3: Association the change of HbA1c and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.body weight (kg), BMI (kg/mm2) 10.detail of medication and number of take medicine 4: Association the change of body weight and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.HbA1c (%) 10.detail of medication and number of take medicine

—

Countries

Japan

Contacts

Public ContactHongo Emi

Nishinihon Hospital Department of Nutrition

hcaelb_a@yahoo.co.jp0963801111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026